全文获取类型
收费全文 | 30177篇 |
免费 | 6291篇 |
国内免费 | 137篇 |
专业分类
耳鼻咽喉 | 672篇 |
儿科学 | 1039篇 |
妇产科学 | 862篇 |
基础医学 | 1321篇 |
口腔科学 | 3276篇 |
临床医学 | 4961篇 |
内科学 | 6580篇 |
皮肤病学 | 565篇 |
神经病学 | 2642篇 |
特种医学 | 1379篇 |
外国民族医学 | 2篇 |
外科学 | 5281篇 |
综合类 | 163篇 |
现状与发展 | 12篇 |
一般理论 | 6篇 |
预防医学 | 3409篇 |
眼科学 | 550篇 |
药学 | 742篇 |
中国医学 | 10篇 |
肿瘤学 | 3133篇 |
出版年
2024年 | 174篇 |
2023年 | 1128篇 |
2022年 | 402篇 |
2021年 | 755篇 |
2020年 | 1284篇 |
2019年 | 602篇 |
2018年 | 1468篇 |
2017年 | 1389篇 |
2016年 | 1598篇 |
2015年 | 1645篇 |
2014年 | 2109篇 |
2013年 | 2594篇 |
2012年 | 1057篇 |
2011年 | 1094篇 |
2010年 | 1557篇 |
2009年 | 2153篇 |
2008年 | 1108篇 |
2007年 | 854篇 |
2006年 | 1034篇 |
2005年 | 825篇 |
2004年 | 697篇 |
2003年 | 591篇 |
2002年 | 559篇 |
2001年 | 646篇 |
2000年 | 539篇 |
1999年 | 600篇 |
1998年 | 584篇 |
1997年 | 564篇 |
1996年 | 619篇 |
1995年 | 472篇 |
1994年 | 367篇 |
1993年 | 318篇 |
1992年 | 384篇 |
1991年 | 360篇 |
1990年 | 343篇 |
1989年 | 372篇 |
1988年 | 322篇 |
1987年 | 337篇 |
1986年 | 286篇 |
1985年 | 266篇 |
1984年 | 241篇 |
1983年 | 196篇 |
1982年 | 155篇 |
1981年 | 136篇 |
1979年 | 169篇 |
1978年 | 142篇 |
1977年 | 134篇 |
1976年 | 140篇 |
1974年 | 133篇 |
1973年 | 146篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
M. Diez L. Favaloro A. Bertolotti J. M. Burgos C. Vigliano M. P. Lastra M. J. Levin A. Arnedo C. Nagel A. G. Schijman R. R. Favaloro 《American journal of transplantation》2007,7(6):1633-1640
Heart transplantation (HTx) is a useful therapy for end‐stage Chaga? cardiomyopathy; however, Chagas reactivation remains a mayor complication. Parasitological methods offer poor diagnostic sensitivity, and use of more sensitive tools such as the Polymerase chain reaction (PCR) is usually necessary. In the present study, reactivation incidence and PCR usefulness for early reactivation diagnosis, as well as for treatment response evaluation during follow‐up, were analyzed using Strout parasite detection test, in 10 of 222 consecutive HTx patients suffering Chagas cardiomyopathy. PCR strategies targeted to minicircle sequences (kDNA, detection limit 1 parasite/ 10 mL blood) and miniexon genes (SL‐DNA, 200 parasite/10 mL) were performed to compare parasite burdens between samples. No patients received prophylactic antiprotozoal therapy (benznidazole). Five patients (50%) exhibited clinical reactivation within a mean period of 71.6 days; positive Strout results were observed in most cases presenting clinical manifestations. kDNA‐PCR was positive 38–85 days before reactivation, whereas SLDNA‐PCR became positive only 7–21 days later, revealing post‐HTx parasitic load enhancement present prior to clinical reactivation development. Reactivations were successfully treated with benznidazole and generated negative PCR results. Results observed in this study indicate the value of PCR testing for an early diagnosis of Chagas reactivation as well as for monitoring treatment efficacy. 相似文献
32.
33.
34.
35.
Susan W. Volk VMD PhD ; Antoneta Radu BS ; Liping Zhang MS ; Kenneth W. Liechty MD 《Wound repair and regeneration》2007,15(5):736-747
Chronic wounds create a formidable clinical problem resulting in considerable morbidity and healthcare expenditure. The etiology for wound healing impairment appears to be multifactorial; however, ischemia is a common factor in most types of chronic wounds. Ideal therapy for such wounds would be to correct deficiencies in growth factors and matrix components and provide cellular precursors required for timely wound closure. We hypothesized that stromal progenitor cell (SPC) therapy could correct the ischemic wound-healing defect through both direct and indirect mechanisms. To test this hypothesis, we used the ischemic rabbit ear model of chronic wound healing. We found that treatment of the wounds with SPCs was able to reverse the ischemic wound-healing impairment, with improved granulation tissue formation and reepithelialization compared with vehicle or bone marrow mononuclear cell controls. In vitro, SPCs were found to produce factors involved in angiogenesis and reepithelialization, and extracellular matrix components, providing evidence for both direct and indirect mechanisms for the observed correction of the healing impairment in these wounds. Treatment of ischemic wounds with SPCs can dramatically improve wound healing and provides a rationale for further studies focused on SPCs as a potential cellular therapy in impaired wound healing. 相似文献
36.
Burness Gene Wenberg MS RD December 《Journal of the American Dietetic Association》2004,104(8):1297-1299
37.
Many people die in emergency departments (EDs) across the United States from sudden illnesses or injuries, an exacerbation of a chronic disease, or a terminal illness. Frequently, patients and families come to the ED seeking lifesaving or life-prolonging treatment. In addition, the ED is a place of transition-patients usually are transferred to an inpatient unit, transferred to another hospital, or discharged home. Rarely are patients supposed to remain in the ED. Currently, there is an increasing amount of literature related to end-of-life care. However, these end-of-life care models are based on chronic disease trajectories and have difficulty accommodating sudden-death trajectories common in the ED. There is very little information about end-of-life care in the ED. This article explores ED culture and characteristics, and examines the applicability of current end-of-life care models. 相似文献
38.
39.
40.